THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY

ABSTRACT BACKGROUND: The enzyme methylenetetrahydrofolate reductase is engaged in DNA synthesis through folate metabolism. Inhibiting the activity of this enzyme increases the susceptibility to mutations, and damage and aberrant DNA methylation, which alters the gene expression of tumor suppressors...

Full description

Bibliographic Details
Main Authors: Evelise Pelegrinelli Zaidan, Michele Tatiana Pereira Tomitão, Marina Alessandra Pereira, Marcia Saldanha Kubrusly, Adriana Vaz Safatle-Ribeiro, Flavio Roberto Takeda, Ivan Cecconello, Ulysses Ribeiro Junior
Format: Article
Language:English
Published: Colégio Brasileiro de Cirurgia Digestiva 2022-09-01
Series:ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100330&tlng=en
_version_ 1828111941250318336
author Evelise Pelegrinelli Zaidan
Michele Tatiana Pereira Tomitão
Marina Alessandra Pereira
Marcia Saldanha Kubrusly
Adriana Vaz Safatle-Ribeiro
Flavio Roberto Takeda
Ivan Cecconello
Ulysses Ribeiro Junior
author_facet Evelise Pelegrinelli Zaidan
Michele Tatiana Pereira Tomitão
Marina Alessandra Pereira
Marcia Saldanha Kubrusly
Adriana Vaz Safatle-Ribeiro
Flavio Roberto Takeda
Ivan Cecconello
Ulysses Ribeiro Junior
author_sort Evelise Pelegrinelli Zaidan
collection DOAJ
description ABSTRACT BACKGROUND: The enzyme methylenetetrahydrofolate reductase is engaged in DNA synthesis through folate metabolism. Inhibiting the activity of this enzyme increases the susceptibility to mutations, and damage and aberrant DNA methylation, which alters the gene expression of tumor suppressors and proto-oncogenes, potential risk factors for esophageal cancer. AIMS: This study aimed to investigate the association between methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and susceptibility to esophageal cancer, by assessing the distribution of genotypes and haplotypes between cases and controls, as well as to investigate the association of polymorphisms with clinical and epidemiological characteristics and survival. METHODS: A total of 109 esophageal cancer patients who underwent esophagectomy were evaluated, while 102 subjects constitute the control group. Genomic DNA was isolated from the peripheral blood buffy coat followed by amplification by polymerase chain reaction and real-time analysis. Logistic regression was used to assess associations between polymorphisms and the risk of developing esophageal cancer. RESULTS: There was no association for methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and haplotypes, with esophageal cancer susceptibility. Esophageal cancer patients carrying methylenetetrahydrofolate reductase 677TT polymorphism had higher risk of death from the disease. For polymorphic homozygote TT genotype, the risk of death significantly increased compared to wild-type genotype methylenetetrahydrofolate reductase 677CC (reference) cases (p=0.045; RR=2.22, 95%CI 1.02–4.83). CONCLUSIONS: There was no association between methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and esophageal cancer susceptibility risk. Polymorphic homozygote genotype methylenetetrahydrofolate reductase 677TT was associated with higher risk of death after surgical treatment for esophageal cancer.
first_indexed 2024-04-11T11:42:46Z
format Article
id doaj.art-edc7b6df66a14a128d0b97e247e19654
institution Directory Open Access Journal
issn 0102-6720
language English
last_indexed 2024-04-11T11:42:46Z
publishDate 2022-09-01
publisher Colégio Brasileiro de Cirurgia Digestiva
record_format Article
series ABCD: Arquivos Brasileiros de Cirurgia Digestiva
spelling doaj.art-edc7b6df66a14a128d0b97e247e196542022-12-22T04:25:47ZengColégio Brasileiro de Cirurgia DigestivaABCD: Arquivos Brasileiros de Cirurgia Digestiva0102-67202022-09-013510.1590/0102-672020220002e1684THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDYEvelise Pelegrinelli Zaidanhttps://orcid.org/0000-0002-9726-3274Michele Tatiana Pereira Tomitãohttps://orcid.org/0000-0003-2010-5646Marina Alessandra Pereirahttps://orcid.org/0000-0002-6865-0988Marcia Saldanha Kubruslyhttps://orcid.org/0000-0003-3258-5632Adriana Vaz Safatle-Ribeirohttps://orcid.org/0000-0001-7686-8859Flavio Roberto Takedahttps://orcid.org/0000-0001-7338-922XIvan Cecconellohttps://orcid.org/0000-0002-3535-4170Ulysses Ribeiro Juniorhttps://orcid.org/0000-0003-1711-7347ABSTRACT BACKGROUND: The enzyme methylenetetrahydrofolate reductase is engaged in DNA synthesis through folate metabolism. Inhibiting the activity of this enzyme increases the susceptibility to mutations, and damage and aberrant DNA methylation, which alters the gene expression of tumor suppressors and proto-oncogenes, potential risk factors for esophageal cancer. AIMS: This study aimed to investigate the association between methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and susceptibility to esophageal cancer, by assessing the distribution of genotypes and haplotypes between cases and controls, as well as to investigate the association of polymorphisms with clinical and epidemiological characteristics and survival. METHODS: A total of 109 esophageal cancer patients who underwent esophagectomy were evaluated, while 102 subjects constitute the control group. Genomic DNA was isolated from the peripheral blood buffy coat followed by amplification by polymerase chain reaction and real-time analysis. Logistic regression was used to assess associations between polymorphisms and the risk of developing esophageal cancer. RESULTS: There was no association for methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and haplotypes, with esophageal cancer susceptibility. Esophageal cancer patients carrying methylenetetrahydrofolate reductase 677TT polymorphism had higher risk of death from the disease. For polymorphic homozygote TT genotype, the risk of death significantly increased compared to wild-type genotype methylenetetrahydrofolate reductase 677CC (reference) cases (p=0.045; RR=2.22, 95%CI 1.02–4.83). CONCLUSIONS: There was no association between methylenetetrahydrofolate reductase 677C>T and methylenetetrahydrofolate reductase 1298A>C polymorphisms and esophageal cancer susceptibility risk. Polymorphic homozygote genotype methylenetetrahydrofolate reductase 677TT was associated with higher risk of death after surgical treatment for esophageal cancer.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100330&tlng=enEsophageal NeoplasmsAdenocarcinomaCarcinoma, Squamous CellPolymorphism, GeneticMethylenetetrahydrofolate Reductase (NADPH2)
spellingShingle Evelise Pelegrinelli Zaidan
Michele Tatiana Pereira Tomitão
Marina Alessandra Pereira
Marcia Saldanha Kubrusly
Adriana Vaz Safatle-Ribeiro
Flavio Roberto Takeda
Ivan Cecconello
Ulysses Ribeiro Junior
THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
Polymorphism, Genetic
Methylenetetrahydrofolate Reductase (NADPH2)
title THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
title_full THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
title_fullStr THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
title_full_unstemmed THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
title_short THYLENETETRAHYDROFOLATE REDUCTASE GENE POLYMORPHISMS AND SUSCEPTIBILITY TO ESOPHAGEAL CANCER: A CASE-CONTROL STUDY
title_sort thylenetetrahydrofolate reductase gene polymorphisms and susceptibility to esophageal cancer a case control study
topic Esophageal Neoplasms
Adenocarcinoma
Carcinoma, Squamous Cell
Polymorphism, Genetic
Methylenetetrahydrofolate Reductase (NADPH2)
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202022000100330&tlng=en
work_keys_str_mv AT evelisepelegrinellizaidan thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT micheletatianapereiratomitao thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT marinaalessandrapereira thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT marciasaldanhakubrusly thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT adrianavazsafatleribeiro thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT flaviorobertotakeda thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT ivancecconello thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy
AT ulyssesribeirojunior thylenetetrahydrofolatereductasegenepolymorphismsandsusceptibilitytoesophagealcanceracasecontrolstudy